| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
106.51 |
21.3 |
127.81 |
4% |
4.26 |
110.77 |
22.15 |
132.92 |
16% |
17.04 |
127.81 |
25.56 |
153.37 |
|
НСР-8984/14.04.2016; НСР-11278/22.12.2016 г. |
02.02.2017 |
02.02.2017 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L., Италия |
108.94 |
21.79 |
130.73 |
4% |
4.36 |
113.3 |
22.66 |
135.96 |
16% |
17.43 |
130.73 |
26.15 |
156.88 |
|
НСР-8332/26.02.2016; НСР-11063/01.12.2016 |
02.01.2017 |
02.01.2017 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
107.16 |
21.43 |
128.59 |
4% |
4.29 |
111.45 |
22.29 |
133.74 |
16% |
17.15 |
128.6 |
25.72 |
154.32 |
|
НСР-8984/14.04.2016 |
30.04.2016 |
30.04.2016 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L., Италия |
110.56 |
22.11 |
132.67 |
4% |
4.42 |
114.98 |
23 |
137.98 |
16% |
17.69 |
132.67 |
26.53 |
159.2 |
|
НСР-8332/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
107.16 |
21.43 |
128.59 |
4% |
4.29 |
111.45 |
22.29 |
133.74 |
16% |
17.15 |
128.6 |
25.72 |
154.32 |
|
НСР-8984/14.04.2016 |
30.04.2016 |
30.04.2016 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L.,Италия |
110.56 |
22.11 |
132.67 |
4% |
4.42 |
114.98 |
23 |
137.98 |
16% |
17.69 |
132.67 |
26.53 |
159.2 |
|
НСР-8332/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L.,Италия |
110.56 |
22.11 |
132.67 |
4% |
4.42 |
114.98 |
23 |
137.98 |
16% |
17.69 |
132.67 |
26.53 |
159.2 |
|
НСР-8332/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
107.16 |
21.43 |
128.59 |
4% |
4.29 |
111.45 |
22.29 |
133.74 |
16% |
17.15 |
128.6 |
25.72 |
154.32 |
|
НСР-8984/14.04.2016 |
30.04.2016 |
30.04.2016 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
108.88 |
21.78 |
130.66 |
4% |
4.36 |
113.24 |
22.65 |
135.89 |
16% |
17.42 |
130.66 |
26.13 |
156.79 |
|
НСР-6847/30.07.2015. |
14.08.2015 |
14.08.2015 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
111.48 |
22.3 |
133.78 |
4% |
4.46 |
115.94 |
23.19 |
139.13 |
16% |
17.84 |
133.78 |
26.76 |
160.54 |
|
НСР-4898/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L.,Италия |
111.48 |
22.3 |
133.78 |
4% |
4.46 |
115.94 |
23.19 |
139.13 |
16% |
17.84 |
133.78 |
26.76 |
160.54 |
|
НСР-3604/23.05.2014 |
06.06.2014 |
06.06.2014 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy |
113.83 |
22.77 |
136.6 |
4% |
4.55 |
118.38 |
23.68 |
142.06 |
16% |
18.21 |
136.59 |
27.32 |
163.91 |
|
НСР-2498/24.01.2014 |
12.02.2014 |
12.02.2014 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy |
37.94 |
7.59 |
45.53 |
4% |
1.52 |
39.46 |
7.89 |
47.35 |
16% |
6.07 |
45.53 |
9.11 |
54.64 |
|
НСР-2498/24.01.2014 |
12.02.2014 |
12.02.2014 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/691/009 |
ELIQUIS, Film coated tablet, 5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L.,Италия |
121.24 |
24.25 |
145.49 |
4% |
4.85 |
126.09 |
25.22 |
151.31 |
16% |
19.4 |
145.49 |
29.1 |
174.59 |
|
НСР-1036/23.08.2013 |
11.09.2013 |
11.09.2013 |
Неактивен |
2819 |
| Apixaban |
EU/1/11/619/003 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy |
132.72 |
26.54 |
159.26 |
4% |
5.31 |
138.03 |
27.61 |
165.64 |
16% |
21.24 |
159.27 |
31.85 |
191.12 |
корекц. КЦPP-2717/20.03.2013 |
КЦРР-2413/22.02.2013 |
17.04.2013 |
17.04.2013 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 60 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone Italy |
44.24 |
8.85 |
53.09 |
4% |
1.77 |
46.01 |
9.2 |
55.21 |
16% |
7.08 |
53.09 |
10.62 |
63.71 |
корекц. КЦPP-2717/20.03.2013 |
КЦРР-2413/22.02.2013 |
17.04.2013 |
17.04.2013 |
Неактивен |
3266 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Ирландия |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
35.19 |
7.04 |
42.23 |
4% |
1.41 |
36.6 |
7.32 |
43.92 |
16% |
5.63 |
42.23 |
8.45 |
50.68 |
Промяна на обстоятелства НСР-20070/30.10.2019 |
НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017; НСР-15143/02.03.2018 |
17.03.2018 |
02.12.2019 |
Активен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
35.19 |
7.04 |
42.23 |
4% |
1.41 |
36.6 |
7.32 |
43.92 |
16% |
5.63 |
42.23 |
8.45 |
50.68 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017; НСР-15143/02.03.2018 |
17.03.2018 |
02.04.2018 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
36.81 |
7.36 |
44.17 |
4% |
1.47 |
38.28 |
7.66 |
45.94 |
16% |
5.89 |
44.17 |
8.83 |
53 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016; НСР-12835/26.05.2017 |
10.06.2017 |
02.07.2017 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
36.87 |
7.37 |
44.24 |
4% |
1.47 |
38.34 |
7.67 |
46.01 |
16% |
5.9 |
44.24 |
8.85 |
53.09 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016 |
02.09.2016 |
02.09.2016 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
36.87 |
7.37 |
44.24 |
4% |
1.47 |
38.34 |
7.67 |
46.01 |
16% |
5.9 |
44.24 |
8.85 |
53.09 |
|
НСР-4899/22.10.2014; НСР-9829/21.07.2016 |
02.09.2016 |
02.09.2016 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
37.16 |
7.43 |
44.59 |
4% |
1.49 |
38.65 |
7.73 |
46.38 |
16% |
5.95 |
44.6 |
8.92 |
53.52 |
|
НСР-4899/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3265 |
| Apixaban |
EU/1/11/619/002 |
ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy |
37.16 |
7.43 |
44.59 |
4% |
1.49 |
38.65 |
7.73 |
46.38 |
16% |
5.95 |
44.6 |
8.92 |
53.52 |
|
НСР-4899/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3265 |
| Metoclopramide |
20160367 |
Elitan, Solution for injection, 10 mg/2 ml, mg, Pack: 100 |
Medochemie Ltd., Кипър |
Medochemie Ltd., Кипър |
97.79 |
19.56 |
117.35 |
4% |
3.91 |
101.7 |
20.34 |
122.04 |
16% |
15.65 |
117.35 |
23.47 |
140.82 |
НСР-12407/18.04.2017 и НСР-12549/28.04.2017 (предварително изпълнение) |
НСР-11549/26.01.2017 г. |
11.02.2017 |
02.05.2017 |
Активен |
15587 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/001 |
Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
306.2 |
61.24 |
367.44 |
4% |
10 |
316.2 |
63.24 |
379.44 |
16% |
25 |
341.2 |
68.24 |
409.44 |
НСР-18704/20.05.2019 и КП-86/14.11.2019 |
НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 |
02.08.2019 |
02.01.2020 |
Активен |
15666 |